Research Radartracking 1,138 published studies · 277 human · 6 safety signals · 42 clinical trials · 44 cancer pages · updated Jul 2026Open the Research Map →

Serous Carcinomas

Serous Carcinomas: treatment map

Standard care plus compounds studied in the literature, organized by clinical readiness.

Educational only. This is not medical advice and not a recommendation. Confirm anything here with your oncology team.

Treatment map: Serous Carcinomas

Standard care plus every compound studied in the literature (each cited) and graded by evidence, organized by clinical readiness. A category, not a verdict that anything works — confirm anything here with your oncology team.

4
Interventions
0
Standard of care
0
Tested in people
0
Lab / animal
4
Named in lit.
2
Classes
Standard of care (0) Guideline option (0) Tested in people (0) Lab / animal only (0) Named in the literature (4)
Investigational & adjunct compounds — detail (4)
Named in the literature
prophylactic oophorectomy· BRCA1 and BRCA2risk-reducing salpingo-oophorectomy· biomarker-selectedrisk-reducing salpingectomy with delayed oophorectomy· biomarker-selectedrecombinant REG4 protein

"Tested in people" rows show the highest trial phase found in that compound's cited human studies (Phase I–IV; "phase not reported" = a human study with no phase tag). "Studied" = named in the cited literature for this cancer. "FDA ✓" = FDA-approved for this cancer; "off-label" = an FDA-approved drug used outside its approved indications (per openFDA). Not a claim that anything works.